What Science&Humans does

Science&Humans is a Canadian digital hormone health platform headquartered in Mississauga, Ontario, founded in 2020 and operating across eight condition-specific programs spanning perimenopause and menopause, early reproductive hormone health (PCOS, PMS, PMDD, endometriosis, thyroid), weight optimization, prescription skincare, hair regrowth, male hormone replacement therapy, and erectile dysfunction. The company serves 60,000+ direct-to-consumer subscribers across Canada through a self-serve web and mobile platform, delivering virtual clinician-led consultations, integrated diagnostics, prescription treatments, and home delivery. Clinical leadership includes Chief Women's Health Advisor Dr. Kristy Prouse (OB/GYN, 30+ years), Chief Men's Health Advisor Dr. Fady Hannah-Shmouni (Clinical Professor of Endocrinology at UBC), and a bench of nurse practitioners specialized in hormone therapy. Operational scale includes 500,000+ prescriptions issued and 1M+ biomarkers tested.

The technology stack combines 20–40+ biomarker comprehensive diagnostics, virtual clinician consultations, prescription pharmacy services, and the Healthspan at-home capillary blood testing device — positioned as Canada's first consumer at-home hormone blood test, with results delivered within 2–3 days. A commercial agreement with SuperQ Quantum Computing targets deployment of hybrid quantum-classical AI clinician systems to enhance diagnostic and treatment processes, though no deployed AI products are disclosed. The company holds LegitScript certification and operates as a vertically integrated platform spanning diagnostics, telehealth, and pharmacy.

Science&Humans operates a subscription-based revenue model with quarterly recurring fees of $150–$200 per program plus prescription medication revenue (topicals, patches, oral therapy, injectable pens priced at $80–$450 per dispensing period). Go-to-market combines direct-to-consumer digital sales, direct B2B enterprise contracts with major Canadian insurance companies for employer-sponsored benefits, and channel partnerships through the Segic Benefits Marketplace for broker and plan-sponsor distribution. The company raised a $10 million oversubscribed Series A in January 2026, combining $7M equity led by Pender Ventures (with participation from WELL Health Technologies, Michele Romanow, and US-based family offices and clinicians) and $3M venture debt from CIBC Innovation Banking. Funding is earmarked to scale nationwide access and deepen employer and insurer partnerships.

Name

Science&Humans

Legal name

Science&Humans

Website

https://scienceandhumans.com

Company type

Private

Founded year

2024

Operating status

Operating

Headcount range

51–100 employees

Short description

Science&Humans is a Canadian digital hormone health platform offering virtual clinician-led diagnosis, treatment, and prescription delivery across perimenopause, menopause, PCOS, low testosterone, and related conditions to 60,000+ DTC subscribers and B2B benefits customers nationwide.

Ownership category

akta.pro rank

Product category

Digital Hormone Health / Telehealth Endocrinology Services

NAICS

Medical and Diagnostic Laboratories (62151), Offices of Physicians (6211)

SIC

Services-Medical Laboratories (8071), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

At-Home Lab Testing & Diagnostics-Integrated Virtual Care (HLALAAAE)

Keywords

• Hormone replacement therapy
• Digital hormone health
• Virtual hormone clinic
• Menopause telehealth care
• At-home hormone diagnostics

Headquarters

HQ city

Mississauga

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel

Revenue model

1. Subscription Recurring (DTC): Quarterly subscription model for direct-to-consumer hormone health programs including unlimited access to care team, virtual consultations, lab monitoring, and prescription management. Programs include Perimenopause & Menopause ($200/quarter ongoing), Early Reproductive Health ($150/quarter), Men's Hormone Health ($200/quarter), and Weight Optimization.
2. Clinical Consultation Fees: One-time clinician consultation fees charged at initial assessment ($50-$200 depending on program) with quarterly follow-up consultations included in subscription.
3. Prescription Medications: Prescription treatments including topical creams ($80-$200/3 months), patches ($150-$250/3 months), oral therapy ($100-$200/3 months), injectable pens ($250-$450/month), and supplements ($20-$67/month) delivered through integrated pharmacy services.
4. B2B Enterprise / Employer Benefits: Enterprise contracts with employers, insurers, and benefits providers to provide hormone health programs as part of employee benefits packages through partnerships like the Segic Benefits Marketplace.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

Science&Humans is a Canadian digital hormone health platform that delivers virtual, clinician-led hormone care programs for women and men. It combines at-home blood diagnostics, comprehensive biomarker testing (20-40+ biomarkers), telehealth consultations with nurse practitioners and physicians, personalized prescription treatment plans (BHRT, TRT, weight optimization medications, prescription skincare, hair regrowth), and direct-to-door medication delivery through an integrated pharmacy. Programs are sold as recurring subscriptions and also distributed through employer benefits marketplaces and insurance partnerships.

Product overview

Science&Humans is a digital hormone health platform offering a comprehensive suite of virtual, clinician-led hormone health programs for both women and men. The platform operates as a modular care ecosystem combining at-home diagnostics (Healthspan), virtual consultations, and personalized treatment plans across multiple condition-specific programs. Women's offerings include Perimenopause & Menopause Treatment, Early Reproductive Hormone Health Program (PCOS, PMS, PMDD, Endometriosis), Weight Optimization, Prescription Skincare, and Hair Regrowth. Men's offerings include Hormone Replacement Therapy (TRT), Weight Optimization, Erectile Dysfunction Treatment, and Hair Regrowth. All programs feature comprehensive biomarker testing (20-40+ biomarkers), unlimited access to care teams, prescription management, and health coaching support.

Differentiator

Problem solved

Functional benefit

Brands

• Healthspan: Canada's first at-home blood test device for hormone biomarker testing, providing convenient at-home diagnostic testing with results delivered within 2-3 days.

Products and services

• Perimenopause & Menopause Treatment Virtual clinician-led Bioidentical Hormone Replacement Therapy (BHRT) program for women in midlife, including 40+ biomarker diagnostics, personalized care plans, and treatments such as topical creams, patches, oral therapy, vaginal therapy, thyroid treatment, arousal treatment, hair regrowth, facial anti-aging, and non-hormonal options.
• Early Reproductive Hormone Health Program Expert-led hormone and metabolic optimization program for women with PCOS, PMS, PMDD, endometriosis, thyroid conditions, and infertility. Includes cycle regulation therapy, metabolic and insulin optimization, anti-inflammatory hormone therapy, thyroid optimization, fertility optimization treatments, and non-hormonal precision therapy.
• Weight Optimization Program Medical weight optimization program with 20+ biomarker testing, personalized treatment plans including injectable pens and oral medications for appetite regulation and metabolic balance, and comprehensive lifestyle coaching. Offered for both men and women.
• Prescription Skincare Program Prescription-grade hormonal skin cream (Estriol 0.3%) for midlife skin concerns including hydration, texture, tone, and elasticity. Includes prescription issuance and automatic refills via licensed pharmacy every 3 months.
• Hair Regrowth Treatment for Women Topical prescription hair regrowth solution for women to slow hormonal hair thinning, promote regrowth, and reduce DHT, delivered every 3 months.
• Male Hormone Replacement Therapy (Hormone Health) Clinician-led Hormone Replacement Therapy for men with 40+ biomarker testing. Treatments include hormone injections, monotherapy, topical creams/gels, oral therapy, and supplements targeting testosterone deficiency, andropause, and age-related hormonal decline.
• Erectile Dysfunction Treatment Prescription treatments for erectile dysfunction delivered discreetly through a virtual care platform with personalized treatment plans and ongoing clinician support.
• Hair Regrowth Treatment for Men Prescription hair regrowth treatments for men to reduce shedding and regrow hair, offered as part of the men's hormone health program.

Quantifiable outcome

• 88% of S&H patients report symptom improvement in 90 days
• +8 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core and strategic.

• SegiccoreGTM or Marketing Partner · 5 June 2026Quebec-based employee benefits technology company. Science&Humans integrates its full suite of virtual, clinician-led hormone health programs into the Segic Benefits Marketplace, enabling employers, brokers, and plan sponsors to offer specialized hormone health services through a digital platform.
• SuperQ Quantum ComputingstrategicTechnology or Integration · 4 November 2025Commercial agreement to deploy quantum-AI clinician systems in healthcare workflows. Collaboration aims to enhance diagnostic and treatment processes using hybrid quantum-classical computing, targeting high accuracy and reliability in sensitive medical applications.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Paloma Health: Telehealth clinic focused on thyroid and hormone-related conditions for women and men. Comparable in condition-specific virtual care model, at-home lab integration, and clinician-led hormone management approach.
• Alloy Women's Health: Telehealth platform for women in menopause offering prescription hormone therapy and ongoing clinician support. Directly comparable to Science&Humans' perimenopause/menopause program in product and audience.
• Winona: Direct-to-consumer telehealth specializing in hormone replacement therapy for women in menopause. Overlaps directly with Science&Humans' perimenopause/menopause program, including online consultations and prescription delivery.
• Fountain TRT: Direct-to-consumer telehealth focused exclusively on men's testosterone replacement therapy. Comparable to Science&Humans' men's hormone program in clinical model, pricing structure, and target demographic.
• Midi Health: U.S.-based virtual care clinic focused on perimenopause and menopause for women. Closest analog to Science&Humans' women's midlife hormone program, with similar clinician-led BHRT model and enterprise/employer distribution focus.
• Evernow: Virtual menopause care platform offering clinician consultations and hormone therapy prescriptions. Comparable in target demographic (women 40+), care delivery model, and condition-specific positioning.

Emerging players

• Maven Clinic: Virtual care platform for women's and family health, including fertility, postpartum, and menopause support with employer/benefits distribution. Comparable in women's virtual care focus and B2B benefits motion.
• Pelago Health: Virtual care platform for substance use, mental health, and chronic conditions, primarily distributed through employer benefits. Comparable in B2B enterprise/employer benefits distribution motion that Science&Humans is building.

Broad incumbents

• Ro (Roman Health): Multi-condition DTC telehealth including men's testosterone replacement, weight management, and women's health. Comparable to Science&Humans across men's TRT and weight programs, though with a much broader portfolio.
• Hims & Hers Health: Large publicly traded DTC telehealth platform spanning men's and women's health, including testosterone therapy, menopause support, and weight loss. Competes with Science&Humans across multiple product lines but at vastly larger scale and broader scope.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Sciencenhumans
• LinkedInlinkedin.com/company/scienceandhumans
• Instagraminstagram.com/scienceandhumans
• Facebookfacebook.com/scienceandhumans.canada

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds4 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Science&Humans